✨ Free AI Report
Celestial Therapeutics Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Celestial Therapeutics Inc.
Company Research

Celestial Therapeutics Inc.: Business Overview, Financials & Competitive Analysis

Celestial Therapeutics is developing novel next generation mRNA vaccines and therapeutics for a variety of indications. The company develops therapies with an emphasis on treating infectious diseases, rare diseases, a...

Analyst-debate audio for Celestial Therapeutics Inc.

AskCyborg analysts argue the bull and bear cases for Celestial Therapeutics Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Early-stage mRNA therapeutics platform with Harvard technology, elite advisors, and J&J validation—positioned to address major...

Read the full analyst-debate transcript →
Industry Biotechnology
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Celestial Therapeutics Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Celestial Therapeutics Inc. Overview

Pro stress-test →

Celestial Therapeutics is developing novel next generation mRNA vaccines and therapeutics for a variety of indications. The company develops therapies with an emphasis on treating infectious diseases, rare diseases, and cancers. The firm leverages proprietary self-adjuvanting mRNA platform technology licensed from Harvard to address significant unmet medical needs.

Strategic Profile

Pro stress-test →

Celestial Therapeutics has been accepted into Johnson & Johnson Innovation – JLABS as a resident company at its flagship site in San Diego, California. Michael Houghton, a Nobel Prize winner in Physiology or Medicine, has joined Celestial's Scientific Advisory Board. The company's strategic approach focuses on developing safer, more efficacious mRNA therapeutics with support from leading academic and industry partners.

Competitive Landscape

Pro stress-test →

Celestial competes in the rapidly evolving mRNA therapeutics space against larger, well-funded biotech companies including BioNTech, Moderna, and CureVac. The differentiation centers on self-adjuvanting technology that combines antigen and immunostimulatory RNA in a single construct, potentially offering improved safety and efficacy profiles. Early-stage positioning limits direct market competition but increases exposure to broader mRNA platform development risks.

Industry Context

Celestial Therapeutics Inc. operates in Biotechnology.

Key facts

Founded: 2019 · Headquarters: Irvine, CA, US · Employees: 2-10

What the analysts stress-tested

The top findings that survived the multi-agent debate for Celestial Therapeutics Inc..

  • Founded October 2019 with a proprietary mRNA platform technology licensed from Harvard.
  • Lead dual modal antiviral/anti-inflammatory therapeutic, CT-02, is advancing into human clinical trials for viral myocarditis treatment via Mayo Clinic Innovation Exchange partnership.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Mayo Clinic Innovation Exchange partnership advancing CT-02 for viral myocarditis into human trials (timeframe not specified in available sources)
  • J&J Innovations JLABS residency at San Diego site (timeframe not specified in available sources)
  • +1 moreTrack every material event for Celestial Therapeutics Inc. as it happens. Explore monitoring →
Get alerted when Celestial Therapeutics Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

ModernamRNA vaccine and therapeutic platform→BioNTechmRNA-based immunotherapies and vaccines→CureVacmRNA therapeutic platform→

Compare Celestial Therapeutics Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Celestial Therapeutics Inc. operates in Biotechnology. See how the rest of the sector scores on the Cyborg framework.

Top companies in Biotechnology by Cyborg Score

Browse Biotechnology research →
NEW · MCP server

Ask your AI assistant about Celestial Therapeutics Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Celestial Therapeutics Inc. and its top competitor on Cyborg Score”
“What did Celestial Therapeutics Inc. do this quarter?”
“Is Celestial Therapeutics Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Celestial Therapeutics Inc. do?+
Celestial Therapeutics is developing novel next generation mRNA vaccines and therapeutics for a variety of indications. The company develops therapies with an emphasis on treating infectious diseases, rare diseases, a...
What is Celestial Therapeutics Inc.'s Cyborg Score?+
Celestial Therapeutics Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Celestial Therapeutics Inc.'s main competitors?+
Named competitors include Moderna, BioNTech, CureVac. The full competitive landscape is in the AskCyborg report.
How can I get the full Celestial Therapeutics Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Celestial Therapeutics Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Celestial Therapeutics Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biotechnology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Abivax SA8Bavarian Nordic A/S8Beam Therapeutics Inc.8CG Oncology, Inc.8Cogent Biosciences, Inc.8COMPASS Pathways plc8CSL Limited8Eckert & Ziegler SE8Krystal Biotech, Inc.8Legend Biotech4Moderna, Inc.7BioNTech SE4CureVac N.V.Top companies in Biotechnology by Cyborg Score